Page last updated: 2024-09-05

phosphatidylcholines and Candidiasis

phosphatidylcholines has been researched along with Candidiasis in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (5.26)	18.7374
1990's	10 (26.32)	18.2507
2000's	25 (65.79)	29.6817
2010's	1 (2.63)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galigama, RD; Garg, P; Mallela, LS; Roy, G; Roy, S; Thorat, VS; Venuganti, VVK	1
Demir, M; Kaldir, M; Turgut, B; Vural, O	1
Kontoyiannis, DP; Mantadakis, E; Samonis, G	1
Butani, L; Jain, A	1
Haq, W; Khan, MA; Nasti, HT; Owais, M; Saima Dagger, K; Shehbaz, A; Syed, FM	1
Barcena, R; Candela, A; de Vicente, E; Fortún, J; García, M; Honrubia, A; Martín-Davila, P; Moreno, S; Nuño, J; Pintado, V; Uriarte, M	1
Brime, B; Frutos, G; Frutos, P; Molero, G	1
Byrd, RG; Cone, LA; Potts, BE; Wuesthoff, M	1
Perfect, JR	1
Hooshmand-Rad, R; Ito, JI	1
Andes, D; Gauthier, GM; Nork, TM; Prince, R	1
Adler-Shohet, FC; Groll, AH; Hempel, G; Lieberman, JM; Walsh, TJ; Würthwein, G	1
Akisu, M; Cetin, H; Hilmioglu, S; Kultursay, N; Metin, D; Yalaz, M	1
Kleinberg, M	1
Olin, JL; Spooner, LM	1
Fohrer, C; Herbrecht, R; Nivoix, Y	1
Cheung, C; Feldmesser, M; Gialanella, P; Guo, Y	1
Calza, L; Manfredi, R	1
Fainstein, V; Hersh, EM; Hopfer, RL; Juliano, R; Kasi, L; Lopez-Berestein, G; Luna, M; Mehta, K; Mehta, R; Mills, K	1
Brajtburg, J; Elberg, S; Kobayashi, GS; Travis, SJ	1
Chanock, SJ; Figg, WD; Gupta, R; Hill, S; Jarosinski, P; Piscitelli, S; Pizzo, PA; Walsh, TJ; Whitcomb, P	1
García Garmendia, JL; Garnacho-Montero, J; Jiménez Jiménez, F; Ortiz-Leyba, C	1
Boyle, JA; Luke, RG	1
Anaissie, EJ; Bow, E; DiNubile, MJ; Hiemenz, JW; Horwith, G; Lee, L; Lister, J; Perfect, JR; Reboli, A; Seibel, NL; Silber, JL; Walsh, TJ	1
Brown, JC; Cohen, MS; Kylstra, JA; Virata, SR; Wohl, DA	1
Arndt, C; Chanock, SJ; Dinubile, MJ; Harris, RE; Hiemenz, J; Reboli, A; Seibel, NL; Walsh, TJ	1
Philips, DL; Sallah, S; Sallah, W; Semelka, RC; Vainright, JR	1
Fraser, SL; Rowles, DM	1
Blowey, DL; Garg, UC; Kearns, GL; Warady, BA	1
Darling, K; Singh, J; Wilks, D	1
Denning, DW; Moore, CB; Morrissey, J; Warn, PA	1
Grau, S; Isbert, F; Nolla-Salas, J; Riveiro, M; Sitges-Serra, A; Torrella, T; Torres-Rodríguez, JM	1
Allaouchiche, B; Chassard, D; Duflo, F	1
Adler-Shohet, F; Lieberman, JM; Waskin, H	1
Andrès, E; Auvrignon, A; Eyer, D; Guillemain, R; Herbrecht, R; Letscher-Bru, V; Leverger, G; Pailler, C; Schaison, G; Suc, A	1
Davis, RD; Drew, RH; Kanj, SS; McConnell, RR; Palmer, SM; Perfect, JR; Tapson, VF; Whitehouse, JD	1
Knoppert, DC; Lee, DS; Salama, HE	1
Allardyce, DB; Groves, AD	1

Reviews

4 review(s) available for phosphatidylcholines and Candidiasis

Article	Year
Systemic mycoses in the immunocompromised host: an update in antifungal therapy. The Journal of hospital infection, 2003, Volume: 53, Issue:4 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles	2003
Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004
What is the current and future status of conventional amphotericin B? International journal of antimicrobial agents, 2006, Volume: 27 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Colloids; Deoxycholic Acid; Drug Combinations; Humans; Liposomes; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome	2006
Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:6 Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols	1999

Trials

5 trial(s) available for phosphatidylcholines and Candidiasis

Article	Year
Population pharmacokinetics of amphotericin B lipid complex in neonates. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12 Topics: Amphotericin B; Anti-Infective Agents; Candida; Candidiasis; Drug Combinations; Humans; Infant, Newborn; Models, Biological; Phosphatidylcholines; Phosphatidylglycerols	2005
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Drug Combinations; Female; Humans; Liver Diseases; Male; Phosphatidylcholines; Phosphatidylglycerols; Splenic Diseases	1997
Renal effects of amphotericin B lipid complex. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Drug Combinations; Female; Humans; Kidney; Male; Meningitis, Cryptococcal; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols	1998
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Cryptococcosis; Drug Combinations; Female; Humans; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols	1998
Amphotericin B lipid complex in pediatric patients with invasive fungal infections. The Pediatric infectious disease journal, 1999, Volume: 18, Issue:8 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis	1999

Other Studies

29 other study(ies) available for phosphatidylcholines and Candidiasis

Article	Year
Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis. International journal of pharmaceutics, 2019, Dec-15, Volume: 572 Topics: Administration, Ophthalmic; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Compressive Strength; Disease Models, Animal; Dosage Forms; Drug Compounding; Drug Delivery Systems; Eye Infections, Fungal; Humans; Keratitis; Male; Miniaturization; Needles; Permeability; Phosphatidylcholines; Polyvinyl Alcohol; Povidone; Rabbits	2019
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B. Annals of hematology, 2002, Volume: 81, Issue:9 Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance; Fatal Outcome; Female; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols	2002
Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Calcium Carbonate; Candidiasis; Cellulitis; Child; Drug Carriers; Female; Headache; Humans; Hyperparathyroidism, Secondary; Immunocompromised Host; Itraconazole; Liposomes; Mucormycosis; Orbital Diseases; Parathyroid Hormone; Phosphates; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Seizures; Sinusitis; Vitamin D	2003
Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B. Journal of drug targeting, 2003, Volume: 11, Issue:2 Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibiotic Prophylaxis; Antifungal Agents; Candida albicans; Candidiasis; Cholesterol; Chromatography, High Pressure Liquid; Female; Liposomes; Mice; Mice, Inbred BALB C; Nystatin; Phosphatidylcholines; Tuftsin	2003
Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Combinations; Female; Humans; Liver Transplantation; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors	2003
Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2004, Volume: 22, Issue:5 Topics: Amphotericin B; Animals; Candidiasis; Chemistry, Pharmaceutical; Deoxycholic Acid; Emulsions; Freeze Drying; Immunocompetence; Male; Mice; Neutropenia; Phosphatidylcholines	2004
Diagnosis and treatment of Candida vertebral osteomyelitis: clinical experience with a short course therapy of amphotericin B lipid complex. Surgical neurology, 2004, Volume: 62, Issue:3 Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Discitis; Drug Administration Schedule; Drug Combinations; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteomyelitis; Phosphatidylcholines; Phosphatidylglycerols; Thoracic Vertebrae	2004
Treatment of Candida infections with amphotericin B lipid complex. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40 Suppl 6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome	2005
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-01, Volume: 41, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Combinations; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure	2005
The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia. Pediatrics international : official journal of the Japan Pediatric Society, 2005, Volume: 47, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Treatment Outcome	2005
Amphotericin B-associated hyperbilirubinemia: case report and review of the literature. Pharmacotherapy, 2006, Volume: 26, Issue:7 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Carcinoma, Non-Small-Cell Lung; Deoxycholic Acid; Drug Combinations; Female; Humans; Hyperbilirubinemia; Liver; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols	2006
Mycograb for the treatment of invasive candidiasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8 Topics: Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Candidiasis; Drug Combinations; HSP90 Heat-Shock Proteins; Humans; Phosphatidylcholines; Phosphatidylglycerols; Recombinant Proteins; Research Design; Survival Analysis	2006
Development of candidemia on caspofungin therapy: a case report. Infection, 2006, Volume: 34, Issue:6 Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Catheters, Indwelling; Cross Infection; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Lipopeptides; Male; Pancreaticoduodenectomy; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications	2006
Concurrence of two different opportunistic mycoses complicated by visceral dissemination diagnosed in "AIDS presenter" patients: candidiasis and cryptococcosis. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis; Cryptococcosis; Drug Combinations; Fungemia; Humans; Phosphatidylcholines; Phosphatidylglycerols; Viscera	2007
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. The Journal of infectious diseases, 1983, Volume: 147, Issue:5 Topics: Amphotericin B; Animals; Candidiasis; Dimyristoylphosphatidylcholine; Liposomes; Mice; Phosphatidylcholines; Phosphatidylglycerols	1983
Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:2 Topics: Amphotericin B; Animals; Bile Acids and Salts; Candidiasis; Cryptococcosis; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred Strains; Micelles; Phosphatidylcholines	1994
Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:4 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Drug Combinations; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Respiration Disorders	1998
Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Infusions, Intravenous; Phosphatidylcholines; Phosphatidylglycerols	1999
Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis. Leukemia research, 1999, Volume: 23, Issue:11 Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Leukemia, Myeloid; Liver Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Splenic Diseases	1999
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1998, Volume: 14 Topics: Amphotericin B; Antifungal Agents; Ascitic Fluid; Candidiasis; Drug Combinations; Drug Therapy, Combination; Fluconazole; Humans; Infant; Infusions, Intravenous; Male; Peritoneal Dialysis; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols	1998
Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC). The Journal of infection, 2000, Volume: 40, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Combinations; Endophthalmitis; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome	2000
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10 Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Fluconazole; Immunocompromised Host; Male; Mice; Microbial Sensitivity Tests; Phosphatidylcholines; Phosphatidylglycerols	2000
Successful treatment with liposomal amphotericin B of an intraabdomianl abscess due to Candida norvegensis associated with a Gore-Tex mesh infection. Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:5 Topics: Abdominal Abscess; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Combinations; Female; Humans; Phosphatidylcholines; Phosphatidylglycerols; Polytetrafluoroethylene; Surgical Mesh	2000
Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex. Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:5 Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biliary Tract; Biliary Tract Neoplasms; Candida; Candidiasis; Drug Combinations; Female; Humans; Phosphatidylcholines; Phosphatidylglycerols	2000
Amphotericin B lipid complex for neonatal invasive candidiasis. Archives of disease in childhood. Fetal and neonatal edition, 2001, Volume: 84, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Creatinine; Drug Combinations; Humans; Infant; Infant, Newborn; Kidney Function Tests; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome	2001
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Leukemia; Lung Transplantation; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies	2001
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation, 2001, Aug-15, Volume: 72, Issue:3 Topics: Adult; Aerosols; Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Heart-Lung Transplantation; Humans; Incidence; Lung Diseases; Lung Transplantation; Middle Aged; Mycoses; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Period; Prospective Studies; Respiratory Mechanics; Safety; Survival Analysis	2001
Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex. The Annals of pharmacotherapy, 2001, Volume: 35, Issue:9 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Phosphatidylcholines; Phosphatidylglycerols; Respiratory Distress Syndrome, Newborn; Treatment Outcome	2001
A comparison of nutritional gains resulting from intravenous and enteral feeding. Surgery, gynecology & obstetrics, 1974, Volume: 139, Issue:2 Topics: Acidosis; Adult; Amino Acids; Candidiasis; Diet; Dietary Carbohydrates; Enteral Nutrition; Gastrointestinal Diseases; Glycine max; Humans; Hyperglycemia; Infusions, Parenteral; Jejunum; Male; Middle Aged; Nutritional Physiological Phenomena; Nutritional Requirements; Oils; Parenteral Nutrition; Phosphatidylcholines; Postoperative Care; Protein Hydrolysates; Sepsis	1974